Examples in this regard include mutations in TP53, PTEN and RB1 in prostate cancer and mutations in TP53, PIK3CA, ERBB2 and KRAS in gastric adenocarcinoma (Kato et al., 2018; Hamid et al., 2019). Here, TP53 is linked to gastric adenocarcinoma.